Primary Cutaneous Follicle Center Lymphoma in a 16-Year-old boy With Crohn Disease Exposed to Infliximab and Methotrexate

J Pediatr Gastroenterol Nutr. 2020 Feb;70(2):e49-e50. doi: 10.1097/MPG.0000000000002578.

Authors

Wael N Sayej^{1

2}, Michael S Isakoff^{3

2}, Joseph A DiGiuseppe⁴, Douglas Moote⁵, Fabiola Balarezo⁴, Christine Finck^{6

2}, Jeffrey S Hyams^{1

2}

Affiliations

¹ Division of Digestive Diseases, Hepatology and Nutrition.
² University of Connecticut School of Medicine, Farmington, CT.
³ Center for Cancer and Blood Disorders, Connecticut Children's Medical Center.
⁴ Department of Pathology and Laboratory Medicine, Hartford Hospital.
⁵ Department of Radiology.
⁶ Department of Pediatric Surgery, Connecticut Children's Medical Center, Hartford.

PMID: 31978035
DOI: 10.1097/MPG.0000000000002578

No abstract available

Publication types

Case Reports

MeSH terms

Adolescent
Crohn Disease* / drug therapy
Humans
Infliximab / adverse effects
Lymphoma, Follicular* / drug therapy
Male
Methotrexate / adverse effects
Skin Neoplasms*

Substances

Infliximab
Methotrexate